The global demand for Thyroid Eye Disease Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Thyroid Eye Disease (TED) also known as Graves' ophthalmopathy, Graves’s eye disease, is an autoimmune medical condition leading to inflammation in the eye muscles, eyelids, tear glands and surrounding tissues. In TED, the immune cells attacks thyroid gland, resulting into hyper/hypo activation of the thyroid gland leading to excessive or low level of secretion of thyroid hormone.
The market is mainly driven by the rise in number of thyroid patients globally. Emergence of new advanced technology and related innovation is another factor driving the market growth. Changing life style, increasing prevalence of the thyroid tumor is also supporting the growth of this market. In addition to this, increase in iodine disorder among the population is boosting the market growth. On the flip side, high cost of the treatment coupled with untrained medical professionals is hindering the market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of thyroid eye disease.
The entire thyroid eye disease market has been sub-categorized into drug type, route of administration, and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Drug Type
By Route Of Administration
By Distribution Channel
- Monoclonal Antibody
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This section covers regional segmentation which accentuates on current and future demand for thyroid eye disease market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Thyroid Eye Disease Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the thyroid eye disease market include Bausch And Lomb Inc., Kala Pharmaceuticals Inc., Pharmos Corp., Hi-Tech Pharmacal Co Inc., Allergan plc, Novartis AG, Eyevance Pharmaceuticals LLC, Pfizer Inc., Horizon Therapeutics plc, and others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.